Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Posted on by sciencefather

Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Dr Mojtaba Aghaei, Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Iran

Mojtaba Aghaei is a Master of Science and Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Iran. 🌟 Specializing in Hematology, Blood Banking, Cancer Therapy, and Cell Signaling, Mojtaba’s research focuses on genetic variants, diabetes mellitus, and chronic lymphoblastic leukemia. 🧬 His projects include systematic reviews and meta-analyses on topics such as advanced glycation end products in PCOS, and the impact of sulfur dioxide on semen quality. With 50 citations and ongoing research on ischemia-modified albumin, his work advances understanding in hematology and endocrinology. 📊🔬

Publication profile

Google scholar

Academic and Professional 

Mojtaba Aghaei is a Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, specializing in Hematology, Blood Banking, and Cancer Therapy. His expertise extends to Cancer Cell Signaling, Flow Cytometry, Cell Culture, Endocrinology, and Gynecology.

Research Projects

Recent studies have explored various aspects of health and disease through systematic reviews and meta-analyses. 🧬 Key areas include the impact of genetic variants on antifungal immunity in hematologic malignancies, associations between Galectin-3 and gestational diabetes, and the role of advanced glycation end products in polycystic ovary syndrome (PCOS). 🔬 Research also investigates the effects of environmental pollutants on semen quality and the influence of biomarkers like Pro-BNP on cardiac health. 📊 Additionally, studies address the correlation between eosinophils and IgE in asthma, and factors influencing acute chest syndrome and thrombotic purpura in sickle cell disease. 🌍💉

Research focus

Based on the provided publications, the research focus of SS Bahreiny appears to be on reproductive health, particularly in the context of polycystic ovary syndrome (PCOS) and male fertility. The systematic reviews and meta-analyses span various aspects, such as oxidative stress, hormonal imbalances, and genetic factors related to PCOS, as well as environmental influences on semen quality. This research aims to understand and improve the diagnosis and treatment of reproductive disorders through comprehensive analyses of circulating biomarkers and environmental impacts. 🧬🔬🩺

Publication top notes

Association of free radical product and polycystic ovary syndrome: A systematic review and meta-analysis

Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis

Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis

The influence of CDKAL1 (rs7754840) gene polymorphism on susceptibility to gestational diabetes mellitus in pregnant women: A systematic review and meta-analysis

Association between ambient particulate matter and semen quality parameters: a systematic review and meta-analysis

Exploring the relationship between ambient sulfur dioxide and semen quality parameters: A systematic review and meta-analysis

Circulating levels of advanced glycation end products in females with polycystic ovary syndrome: a meta-analysis

Genetic Variants of Dectin-1 and their antifungal immunity impact in Hematologic Malignancies: A Comprehensive Systematic Review

A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis

 

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Posted on by sciencefather

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

 

 

Bijo Mathew | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Prof Dr. Bijo Mathew | Medicinal Chemistry | Best Researcher Award

Professor at Amrita School of Pharmacy India.

Prof. Dr. Bijo Mathew is a distinguished academic in pharmaceutical sciences, currently serving as a Professor at Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi. With a robust background in molecular docking and drug design using AutoDock 4.2, Biovia, and Glide, he contributes significantly as Section Editor for Coronaviruses (BenthamScience) and Editorial Member for several prestigious journals. Dr. Mathew’s teaching career spans from Assistant Professor to his current role, imparting knowledge across various institutions in India. He is a sought-after speaker, delivering talks internationally and nationally on drug design and medicinal chemistry. Recognized as one of the Top 2% Scientists by Stanford, he has received multiple awards including the Amrita Publication Research Award and Best International Collaborator Award. Dr. Mathew holds patents for compositions addressing neurological disorders, underscoring his commitment to advancing pharmaceutical research and education.

Professional Profiles:

🎓 Education

Prof. Dr. Bijo Mathew boasts a distinguished academic journey in pharmaceutical sciences, culminating in a Ph.D. from Jawaharlal Nehru Technological University, Hyderabad, India, specializing in Pharmaceutical Science. Prior to his doctoral studies, he completed his Master’s in Pharmaceutical Chemistry and Bachelor’s in Pharmacy at The Tamilnadu Dr. M.G.R. Medical University, Chennai, and his pre-degree at Mahatma Gandhi University, Kottayam, India. His doctoral research under the guidance of Dr. A. Jerad Suresh focused on the synthesis, characterization, and pharmacological evaluation of heterocyclic derivatives, contributing significantly to the field. Prof. Mathew’s academic journey is marked by a commitment to advancing pharmaceutical knowledge, evident in his extensive expertise across various domains of pharmaceutical research, including molecular docking, dynamics, and pharmacophore mapping. His educational foundation and research acumen continue to drive innovative contributions in drug discovery and development, positioning him as a prominent figure in academia and pharmaceutical research.

Area of Interest and Expertise

Prof. Dr. Bijo Mathew’s research interests encompass a diverse array of fields within pharmaceutical chemistry and drug discovery. His expertise spans the chemistry and biological exploration of various classes of compounds such as chalcones and isatins. He is involved in the synthesis and pharmacological evaluation of heterocyclic nuclei including benzimidazole, thiadiazole, pyrimidine, furan, pyrazoline, and thiazole derivatives, focusing on their potential as CNS depressants, anticonvulsants, anticancer agents, antioxidants, and neuroprotective compounds. Dr. Mathew specializes in designing inhibitors for key enzymes like MAO, AChE, BACE1, and Hsp90, utilizing techniques such as monowave-assisted synthesis and structural elucidation through IR, NMR, and MASS spectroscopy. His research also extends to molecular docking, dynamics, pharmacophore mapping, and 3D-QSAR studies, as well as the isolation and computational analysis of natural secondary metabolites from medicinal plants.

Expertise in Software:

  • AutoDock 4.2, Biovia, Glide

Editorial Contributions:

  • Section Editor for Coronaviruses (BenthamScience)
  • Editorial Member for Brain Sciences (MDPI), Combinatorial Chemistry & High Throughput Screening (Bentham Science), Molecules (MDPI), Current Topics in Medicinal Chemistry (Bentham Science), Current Drug Targets (Bentham Science)

Teaching Experience:

  • Professor at Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, India, since April 2022
  • Associate Professor and Assistant Professor at various institutions in India prior to current position

Invited Talks:

  • Presented internationally and nationally on topics related to drug design, molecular docking, and medicinal chemistry.

Awards and Recognition:

  • Recognized with multiple awards including Top 2% Scientists from Stanford, Amrita Publication Research Award, Best International Collaborator Award, Chancellor’s Publication Award, Publication Merit Award, and Best Resource Person Award at National College of Pharmacy.

Patents:

  • Granted patents on compositions for neurological disorders and therapeutic agents.

Publications

  1. Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches
    • Authors: Manaithiya, A., Bhowmik, R., Acharjee, S., Parkkila, S., Aspatwar, A., Mathew, B.
    • Year: 2024
    • Citations: 0
  2. Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors
    • Authors: Kumar, S., Bhowmik, R., Oh, J.M., Kim, H., Mathew, B.
    • Year: 2024
    • Citations: 3
  3. Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
    • Authors: Lee, J., Parmbil, S.K., Pandit, N.K., Kim, H., Mathew, B.
    • Year: 2024
    • Citations: 0
  4. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect
    • Authors: Kumar, S., Oh, J.M., Prabhakaran, P., Kim, H., Mathew, B.
    • Year: 2024
    • Citations: 3
  5. MzDOCK: A free ready-to-use GUI-based pipeline for molecular docking simulations
    • Authors: Kabier, M., Gambacorta, N., Trisciuzzi, D., Nicolotti, O., Mathew, B.
    • Year: 2024
    • Citations: 0
  6. Design and Synthesis of the Linezolid Bioisosteres to Resolve the Serotonergic Toxicity Associated with Linezolid
    • Authors: Girase, R.T., Ahmad, I., Oh, J.M., Kim, H., Patel, H.M., Mathew, B.
    • Year: 2024
    • Citations: 0
  7. MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer’s Disease
    • Authors: Sasidharan, R., Mohanan, R., Kukreti, N., Manju, S.L., Mathew, B.
    • Year: 2024
    • Citations: 0
  8. Correction to: Targeting cellular batteries for the therapy of neurological diseases (Environmental Science and Pollution Research)
    • Authors: Arora, A., Behl, T., Sehgal, A., Mathew, B., Bungau, S.
    • Year: 2024
    • Citations: 0
  9. Chalcones with N-Methylpiperazine Moiety: Synthesis, Monoamine Oxidase Inhibition, Neuroprotective Effect and Computer Simulation Study
    • Authors: Jayan, J., Trisciuzzi, D., Benny, F., Nicolotti, O., Mathew, B.
    • Year: 2024
    • Citations: 0
  10. A structure-based approach to explore novel COX-2 inhibitors using pharmacophore modelling, 3D-QSAR analysis, virtual screening and dynamics simulation study
    • Authors: Krishnendu, P.R., Benny, S., Kumar, S., Zachariah, S.M., Mathew, B.
    • Year: 2024
    • Citations: 3

 

 

Tugba Agbal | Medicine and Health Sciences | Best Researcher Award

Posted on by sciencefather

Ms. Tugba Agbal | Medicine and Health Sciences | Best Researcher Award

Specialist Doctor at Ankara Etlik City Hospital, Turkey.

Dr. Tuğba Ağbal is a dedicated specialist in obstetrics and gynecology, currently serving at Etlik City Hospital. She completed her residency at The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital and earned her medical degree from Gazi University Faculty of Medicine. Dr. Ağbal’s professional experience includes significant roles at both Etlik City Hospital and Bulanık Public Hospital. Her research interests focus on reproductive health, prenatal and postnatal care, and innovative surgical techniques. She has received multiple awards and honors, including competency certificates in laparoscopic and hysteroscopic interventions, obstetric ultrasonography, neonatal resuscitation, and various therapeutic practices. Dr. Ağbal’s research skills are robust, encompassing clinical study design, statistical analysis, literature review, and collaboration. Her contributions to women’s health are marked by her compassionate approach to patient care and her commitment to advancing medical knowledge and improving clinical outcomes.

Professional Profiles:

Education 🎓

Tuğba Ağbal completed her Obstetrics and Gynecology Residency at The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital in Ankara, Turkey, from 2016 to 2021. Prior to her residency, she earned her medical degree from Gazi University Faculty of Medicine, also in Ankara, where she studied from 2009 to 2015. Her educational journey began at Hacı Ömer Tarman Science High School in Ankara, where she completed her high school education from 2005 to 2009.

Professional Experience

Since February 2023, Tuğba Ağbal has been working as a specialist in the Obstetrics and Gynecology Clinic at Etlik City Hospital. Prior to this, she served as a specialist in the Obstetrics and Gynecology Clinic at Bulanık Public Hospital from 2022 to 2023. Her professional journey has been marked by a dedication to women’s health, with a focus on providing comprehensive care in obstetrics and gynecology. During her tenure at these hospitals, she has gained extensive experience in managing a variety of cases, ranging from routine prenatal and postnatal care to complex gynecological surgeries. Dr. Ağbal’s commitment to her field is evident through her continuous pursuit of professional development and her active involvement in clinical practice, ensuring she stays at the forefront of medical advancements. Her work is characterized by a compassionate approach to patient care and a strong commitment to improving women’s health outcomes.

Research Interest

Tuğba Ağbal’s research interests are primarily focused on obstetrics and gynecology, with a particular emphasis on improving clinical outcomes and advancing medical knowledge in women’s health. She is deeply interested in the study of reproductive health, prenatal and postnatal care, and the management of gynecological disorders. Her work includes investigating innovative approaches to treat conditions such as pelvic floor organ prolapse and postpartum complications. Additionally, she is keen on exploring the impacts of various medical interventions on maternal and fetal health. Dr. Ağbal is also interested in the development and assessment of new methodologies for gynecological surgeries and minimally invasive techniques. Her research aims to enhance the understanding and treatment of female reproductive health issues, contributing to better patient care and outcomes.

Award and Honors

Tuğba Ağbal has received several awards and honors throughout her career. She was awarded the Laparoscopic Intervention Competency Achievement Certificate from The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital in Ankara, Turkey. She also earned the Hysteroscopic Intervention Competency Achievement Certificate from the same institution. Additionally, Dr. Ağbal completed training and received competency certification for basic obstetric ultrasonography in both the first and second trimesters. She has been recognized for her expertise in neonatal resuscitation by the Turkish Ministry of Health, General Directorate of Public Health, Department of Child and Adolescent Health. Furthermore, she holds certifications in colposcopy, divorce therapy, sexual therapy, and marriage and couple therapy from the Relationship Therapies Institute. These accolades highlight her dedication to professional development and excellence in her field.

Research Skills

Tuğba Ağbal possesses a comprehensive set of research skills that enhance her expertise in obstetrics and gynecology. She is proficient in designing and conducting clinical studies, particularly those related to women’s reproductive health. Her skills include statistical analysis and data interpretation, which are crucial for evaluating research outcomes and drawing meaningful conclusions. Dr. Ağbal is experienced in writing and reviewing scientific manuscripts, contributing to her ability to publish research findings in reputable journals. She is adept at using various research methodologies, including both qualitative and quantitative approaches, to explore complex medical issues. Additionally, her skills in literature review and meta-analysis enable her to synthesize existing research and identify gaps in knowledge. Dr. Ağbal’s ability to collaborate with multidisciplinary teams and her commitment to ethical research practices further underscore her capabilities as a researcher in the field of obstetrics and gynecology.

 

 

Valery Likhvantsev | Medicine and Health Sciences | Russia

Posted on by sciencefather

Prof Dr. Valery Likhvantsev | Medicine and Health Sciences | Russia

Deputy Director at Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia.

Amjad Alipanah is an esteemed Associate Professor of Applied Mathematics at the University of Kurdistan, Sanandaj, Iran. Born on September 23, 1974, he has a distinguished academic background with a BSc in Mathematics from the University of Kurdistan and both an MSc and PhD in Applied Mathematics from AmirKabir University, Tehran, Iran. His research focuses on spectral and pseudospectral methods, finite difference methods, calculus of variations, approximation theory, and numerical analysis. With a robust portfolio of journal publications and conference papers, he has significantly contributed to the field. Alipanah is also a dedicated educator, teaching a variety of undergraduate and graduate courses and supervising numerous postgraduate theses. His work has earned him top ranks as a graduate student and a prominent position in the academic community. 🌐✨

Professional Profiles:

Education

Valery Likhvantsev’s education details are not explicitly provided in the information available. To accurately provide his educational background, additional specific details about his academic journey, such as the institutions he attended, degrees he obtained, and fields of study, would be required. However, considering his high level of research activity and professional accomplishments, it can be inferred that he has a robust educational foundation in medicine or a related field, likely including advanced degrees such as an MD or PhD.

Professional Experience

Valery Likhvantsev is currently affiliated with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology since 2020. His extensive professional experience spans various roles and contributions to the field of anesthesiology and intensive care. Likhvantsev has authored and co-authored numerous publications in high-impact journals, reflecting his active engagement in clinical research and his commitment to advancing medical knowledge in his specialty. His work includes significant contributions to contemporary clinical trials, systematic reviews, and meta-analyses, focusing on topics such as neurocognitive disorders, sepsis, and postoperative outcomes. His professional journey underscores a deep commitment to clinical excellence and research innovation in critical care medicine.

Research Interest

Valery Likhvantsev’s research interests primarily revolve around anesthesiology and intensive care medicine. His work extensively covers the effects of anesthetics on postoperative neurocognitive disorders, the use of anti-inflammatory agents in sepsis, and strategies to reduce postoperative agitation through innovative anesthetic techniques. Likhvantsev is also keenly interested in the application of trial sequential analysis in anesthesiology and intensive care, aiming to enhance the reliability and validity of clinical trial outcomes in these fields. His research is characterized by a rigorous approach to understanding and improving patient outcomes through evidence-based practices and innovative therapeutic interventions.

Award and Honors

Valery Likhvantsev has been recognized for his significant contributions to anesthesiology and intensive care medicine. His awards and honors reflect his dedication to advancing the field through innovative research and clinical excellence. He has received multiple accolades for his published works, highlighting the impact and importance of his research in improving patient outcomes and advancing medical knowledge. These honors underline Likhvantsev’s role as a leading figure in his area of expertise, acknowledging his commitment to excellence and his influence in shaping contemporary anesthesiology and intensive care practices.

Research Skills

Valery Likhvantsev possesses a robust set of research skills that underscore his expertise in anesthesiology and intensive care medicine. His proficiency in clinical trial design and implementation ensures rigorous and reliable study outcomes, while his adeptness in systematic reviews and meta-analyses enables comprehensive evaluations of existing research. He is skilled in statistical analysis, which allows for precise interpretation of complex data, and his ability to conduct trial sequential analysis adds a layer of depth to his research. Additionally, Likhvantsev is proficient in writing and publishing scholarly articles, contributing to high-impact journals in his field, thus disseminating crucial findings to the wider medical community.

Publications

  1. Sevoflurane Multiple Wash In/Wash Out at the End of Anesthesia to Reduce Agitation: A Multicenter Double-Blind Randomized Controlled Trial
    • Authors: Landoni, G., Likhvantsev, V.V., Berikashvili, L.B., Pivovarova, A.A., Shemetova, M.M.
    • Year: 2024
    • Citations: 0
    • Journal: Contemporary Clinical Trials Communications
  2. Trial Sequential Analysis in Anesthesiology and Intensive Care: A Systematic Review | Последовательный анализ исследований в анестезиологии и реаниматологии: систематический обзор
    • Authors: Yadgarov, M.Ya., Berikashvili, L.B., Polyakov, P.A., Yakovlev, A.A., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Patologiya Krovoobrashcheniya i Kardiokhirurgiya
  3. Intraoperative Electroencephalogram Patterns as Predictors of Postoperative Delirium in Older Patients: A Systematic Review and Meta-Analysis
    • Authors: Likhvantsev, V.V., Berikashvili, L.B., Smirnova, A.V., Shemetova, M.M., Kuzovlev, A.N.
    • Year: 2024
    • Citations: 0
    • Journal: Frontiers in Aging Neuroscience
  4. Effect of Regional Anesthesia on Oncological Outcomes (Meta-Analysis)
    • Authors: Kadantseva, K.K., Yadgarov, M.Ya., Subbotin, V.V., Kuzovlev, A.N., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Obshchaya Reanimatologiya
  5. Melatonin as Adjuvant Treatment in COVID-19 Patients: A Meta-Analysis of Randomized and Propensity Matched Studies
    • Authors: Tóth, K., Pilia, E., Landoni, G., Székely, A., Covello, R.D.
    • Year: 2024
    • Citations: 0
    • Journal: Signa Vitae
  6. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
    • Authors: Marcucci, M., Painter, T.W., Conen, D., Yusuf, S., Devereaux, P.J.
    • Year: 2023
    • Citations: 1
    • Journal: Annals of Internal Medicine
  7. Effects of Early Postoperative Neurocognitive Disorders on Clinically Relevant Outcomes: A Meta-Analysis
    • Authors: Likhvantsev, V.V., Landoni, G., Berikashvili, L.B., Makarevich, D.M., Grechko, A.V.
    • Year: 2023
    • Citations: 2
    • Journal: Korean Journal of Anesthesiology
  8. High Dose Esomeprazole as an Anti-Inflammatory Agent in Sepsis: Protocol for a Randomized Controlled Trial
    • Authors: Monti, G., Konkayev, A., Carta, S., Usai, B., De Sio, A.
    • Year: 2023
    • Citations: 0
    • Journal: Contemporary Clinical Trials
  9. Anakinra for Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
    • Authors: Cavalli, G., Navalesi, P., Landoni, G., Monti, G., Pasin, L.
    • Year: 2023
    • Citations: 1
    • Journal: Signa Vitae
  10. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The MERCY Randomized Clinical Trial
    • Authors: Monti, G., Bradić, N., Marzaroli, M., Bellomo, R., Zangrillo, A.
    • Year: 2023
    • Citations: 22
    • Journal: JAMA